Predict your next investment

HEALTHCARE | Biotechnology
aurabiosciences.com

See what CB Insights has to offer

Competitors

14

Business Relationships

2

Service Providers

1

Aura Biosciences Competitors & Alternatives

14 Competitors

Aura Biosciences has 14 competitors. Aura Biosciences's competitors are Catalent, Intercell, Glide Pharma, Pacira Biosciences, Azaya Therapeutics and more.

Latest Funding

Companies

Investment Stage

Total Funding

Mosaic
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

Location

7/31/2014

IPO

New Jersey

5/29/2013

Acq - P2P

Austria

2/26/2013

Series D

$42.6M

United Kingdom

4/13/2012

IPO

$111.25M

California

9/16/2009

Grant

$1.04M

Texas

11/7/2007

FORMAC Pharmaceuticals N.V.

Unattributed VC

$2.4M

Belgium

8/22/2007

MedManage Systems

Series E

$41.25M

Washington

5/9/2005

Spherics

Series C

$40.48M

Massachusetts

Nano Discovery

Florida

Glycologic

United Kingdom

Latest Funding

7/31/2014

5/29/2013

2/26/2013

4/13/2012

9/16/2009

11/7/2007

8/22/2007

5/9/2005

Companies

FORMAC Pharmaceuticals N.V.

MedManage Systems

Spherics

Nano Discovery

Glycologic

Investment Stage

IPO

Acq - P2P

Series D

IPO

Grant

Unattributed VC

Series E

Series C

Total Funding

$42.6M

$111.25M

$1.04M

$2.4M

$41.25M

$40.48M

Mosaic

Location

New Jersey

Austria

United Kingdom

California

Texas

Belgium

Washington

Massachusetts

Florida

United Kingdom

Aura Biosciences Service Providers

1 Service Provider

Aura Biosciences has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Series C

Investment Bank

Financial Advisor

Service Provider

Associated Rounds

Series C

Provider Type

Investment Bank

Service Type

Financial Advisor

Partnership data by VentureSource

Aura Biosciences Partners & Customers

2 Partners and customers

Aura Biosciences has 2 strategic partners and customers. Aura Biosciences recently partnered with Clearside Biomedical on July 7, 2019.

Date

Type

Business Partner

Country

News Snippet

Sources

7/9/2019

Licensee

Clearside Biomedical

United States

Clearside Biomedical Announces License Agreement with Aura Biosciences for Suprachoroidal Space Microinjector™ Designed to Optimize Ocular Oncology Drug Delivery

We believe Aura Biosciences is an ideal partner for our targeted Suprachoroidal Space that has the potential to optimize dosing and administration of their ocular anti-cancer drug candidates , with the goal of bringing promising new treatments to patients suffering from ocular cancers such as choroidal melanoma . ''

3

12/31/2018

Licensor

Clearside Biomedical

United States

Subscribe to see more

Subscribe to see more

10

Date

7/9/2019

12/31/2018

Type

Licensee

Licensor

Business Partner

Clearside Biomedical

Clearside Biomedical

Country

United States

United States

News Snippet

Clearside Biomedical Announces License Agreement with Aura Biosciences for Suprachoroidal Space Microinjector™ Designed to Optimize Ocular Oncology Drug Delivery

We believe Aura Biosciences is an ideal partner for our targeted Suprachoroidal Space that has the potential to optimize dosing and administration of their ocular anti-cancer drug candidates , with the goal of bringing promising new treatments to patients suffering from ocular cancers such as choroidal melanoma . ''

Subscribe to see more

Subscribe to see more

Sources

3

10

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.